An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug
- 1 June 1997
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 53 (11) , 1569-1575
- https://doi.org/10.1016/s0006-2952(97)00040-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Regulation of ribosomal gene transcriptionBiochemical Journal, 1995
- In vitro splicing of pre-messenger RNA with extracts from 5-fluorouridine-treated cellsBiochemical Journal, 1994
- Current Role of Chemotherapy in Head and Neck CancerDrugs, 1992
- Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulatorsPharmacology & Therapeutics, 1991
- Inhibition of pre-mRNA splicing by 5-fluoro-, 5-chloro-, and 5-bromouridinePublished by Elsevier ,1989
- 5-Fluorouracil substitution alters pre-mRNA splicing in vitro.Journal of Biological Chemistry, 1988
- Potentiation of the anti-tumor activity of 5FU by thymidine and its correlation with the formation of (5FU) RNACancer, 1980
- A reinvestigation of 5′→3′ polarity in 40S ribosomal RNA precursor of xenopus laevisCell, 1976
- Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylateBiochemistry, 1974
- Mutagenesis of bacteriophage PBS 2Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1973